-transparent.png){kind=logo}
1. Seven patients with TD were treated with a single dose of ceruletide 0.8 microgram/kg i.m. 2. EMG and MV were recorded, and the average power spectrum was computed. 3. Effect of ceruletide on TD within 2 hr after injection was varied (3 cases: inhibitory, 2 cases: facilitatory, 2 cases: no effect). 4. Two patients with severe TD, who showed improvement after a single administration, received repeated administration of ceruletide (0.6 microgram/kg i.m.) and their TD symptoms were recorded on videotape for blind consensus ratings. In both patients ceruletide caused a marked decrease in severity of TD, and the effects lasted for several weeks. 5. The present findings might contribute to further understanding of the role of CCK in the brain and to the treatment of TD.
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
August 1992,
Psychiatry research,
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
April 2011,
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology,
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
January 1988,
Progress in neuro-psychopharmacology & biological psychiatry,
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
August 1982,
The Journal of clinical psychiatry,
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
February 2001,
The Journal of clinical psychiatry,
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
August 1982,
The Journal of clinical psychiatry,
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
August 1988,
Journal of clinical psychopharmacology,
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
May 2010,
Neurotoxicity research,
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
November 1979,
The American journal of psychiatry,
T Nishikawa, and
M Tanaka, and
A Tsuda, and
I Koga, and
Y Uchida
May 2020,
Neurologic clinics,
